The influence of physician recommendation on prostate-specific antigen screening

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 10, 2015, Pages 424.e1-424.e7

  Pucheril, Daniel ^a   Dalela, Deepansh ^a   Sammon, Jesse ^a   Sood, Akshay ^a   Sun, Maxine ^b   Trinh, Quoc Dien ^b   Menon, Mani ^a   Abdollah, Firas ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Physician influence; Prostate specific antigen; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CLINICAL DECISION MAKING; HUMAN; MALE; MIDDLE AGED; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN SCREENING; AGED; ATTITUDE TO HEALTH; BLOOD; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; EARLY CANCER DIAGNOSIS; PROCEDURES; PROSTATIC NEOPLASMS; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PRACTICE PATTERNS, PHYSICIANS'; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84942195523     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.06.013     Document Type: Article

References (28)

1. Moyer V.A. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012, 157(2):120-134.
2. Carter H.B., Albertsen P.C., Barry M.J., et al. Early detection of prostate cancer: AUA guideline. J Urol 2013, 190(2):419-426.
3. Society AC. American Cancer Society recommendations for prostate cancer early detection, ; 2015. http://www.cancer.org/cancer/prostatecancer/moreinformation/prostatecancerearlydetection/prostate-cancer-early-detection-acs-recommendations.
4. [accessed 11.12.13]. http://www.cdc.gov/brfss/.%20http:/www.cdc.gov/brfss/.
5. Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey data, ; 2012 [accessed 01.01.15]. http://www.cdc.gov/brfss/annual_data/2012/pdf/Overview_2012.pdf.
6. Aizer A.A., Falit B., Mendu M.L., et al. Cancer-specific outcomes among young adults without health insurance. J Clin Oncol 2014, 32(19):2025-2030.
7. Woods V.D., Montgomery S.B., Herring R.P., Gardner R.W., Stokols D. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men. J Natl Med Assoc 2006, 98:492-504.
8. Hosain G.M., Sanderson M., Du X.L., Chan W., Strom S.S. Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. Cent Eur J Public Health 2011, 19:30-34.
9. Drazer M.W., Huo D., Schonberg M.A., Razmaria A., Eggener S.E. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol 2011, 29:1736-1743.
10. Sammon J.D., Pucheril D., Diaz M., et al. Contemporary nationwide patterns of self-reported prostate-specific antigen screening. JAMA Intern Med 2014, 174:1839-1841.
11. Wee C.C., McCarthy E.P., Phillips R.S. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005, 41:23-29.
12. Klabunde C.N., Vernon S.W., Nadel M.R., Breen N., Seeff L.C., Brown M.L. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 2005, 43:939-944.
13. Klabunde C.N., Schenck A.P., Davis W.W. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med 2006, 30:313-319.
14. Jaramillo E., Tan A., Yang L., Kuo Y.F., Goodwin J.S. Variation among primary care physicians in prostate-specific antigen screening of older men. J Am Med Assoc 2013, 310(15):1622-1624.
15. Hayat Roshanai A., Nordin K., Berglund G. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer. Acta Oncol 2013, 52:1602-1608.
16. Hayes J.H., Barry M.J. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. J Am Med Assoc 2014, 311:1143-1149.
17. Han P.K., Kobrin S., Breen N., et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med 2013, 11:306-314.
18. Li J., Berkowitz Z., Richards T.B., Richardson L.C. Shared decision making in prostate-specific antigen testing with men older than 70 years. J Am Board Fam Med 2013, 26:401-408.
19. Evans R., Joseph-Williams N., Edwards A., et al. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial. J Med Internet Res 2010, 12:e27.
20. Taylor K.L., Williams R.M., Davis K., et al. Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. JAMA Intern Med 2013, 173:1704-1712.
21. Williams R.M., Davis K.M., Luta G., et al. Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer. Patient Educ Couns 2013, 91:329-336.
22. Feng B., Srinivasan M., Hoffman J.R., et al. Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits. Ann Fam Med 2013, 11:315-323.
23. Prasad S.M., Drazer M.W., Huo D., Hu J.C., Eggener S.E. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. J Am Med Assoc 2012, 307:1692-1694.
24. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 149:185-191. U.S. Preventive Services Task Force.
25. Cohn J.A., Wang C.E., Lakeman J.C., et al. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. Urol Oncol 2014, 32:41e23-41e30.
26. Kim S.P., Karnes R.J., Nguyen P.L., et al. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer. BJU Int 2014, 113:E106-E111.
27. Sayre E.C., Bunting P.S., Kopec J.A. Reliability of self-report versus chart-based prostate cancer, PSA, DRE and urinary symptoms. Can J Urol 2009, 16(1):4463-4471.
28. Hall H.I., Van Den Eeden S.K., Tolsma D.D., et al. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med 2004, 39:27-35.